Influenza B Lineages Have More in Common Than Meets the Eye. Trivalent Influenza Vaccines Trigger Heterotypic Antibodies Against Both Influenza B Viruses
Influenza B is accountable for an important burden during flu epidemics, causing special impact in children and the elderly. Vaccination is the best approach to address influenza infections. However, one of the main problems of this virus is that two different lineages circulate together, Victoria a...
Guardado en:
Autores principales: | , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/871c36e087884470a75a19a47cee3f9f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:871c36e087884470a75a19a47cee3f9f |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:871c36e087884470a75a19a47cee3f9f2021-11-11T09:02:48ZInfluenza B Lineages Have More in Common Than Meets the Eye. Trivalent Influenza Vaccines Trigger Heterotypic Antibodies Against Both Influenza B Viruses1664-302X10.3389/fmicb.2021.737216https://doaj.org/article/871c36e087884470a75a19a47cee3f9f2021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fmicb.2021.737216/fullhttps://doaj.org/toc/1664-302XInfluenza B is accountable for an important burden during flu epidemics, causing special impact in children and the elderly. Vaccination is the best approach to address influenza infections. However, one of the main problems of this virus is that two different lineages circulate together, Victoria and Yamagata; and trivalent vaccines, that only contain one of these lineages, are still in use. For that reason, if during an epidemic, the lineage not included in the vaccine predominates, a mismatch would occur, and the vaccine effectiveness will be very poor. In this work, we evaluated the cross-protection given by the trivalent Influenza vaccine and compared serological profiles based on age, sex, and the type of vaccine used. We performed a retrospective analysis of serum samples obtained before and after seasonal influenza vaccination during 20 seasons (1998–2018). The results showed that heterotypic reactivity between both influenza B lineages is common, but always lower than the homologous response. Age is a relevant factor for this cross-reactivity between both lineages, while the sex and the type of vaccine not. Vaccination with trivalent influenza vaccines elicits cross-reactive antibodies against both lineages, however, this response might not be enough to provide an appropriate serological protection in case of mismatch.Laura Sánchez-de PradaLaura Sánchez-de PradaSilvia Rojo-RelloSilvia Rojo-RelloMarta Domínguez-GilMarta Domínguez-GilEduardo Tamayo-GómezRaúl Ortiz de Lejarazu-LeonardoJosé María EirosJosé María EirosJosé María EirosIván Sanz-MuñozFrontiers Media S.A.articleinfluenza Bcross-immunityageelderlysexvaccinesMicrobiologyQR1-502ENFrontiers in Microbiology, Vol 12 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
influenza B cross-immunity age elderly sex vaccines Microbiology QR1-502 |
spellingShingle |
influenza B cross-immunity age elderly sex vaccines Microbiology QR1-502 Laura Sánchez-de Prada Laura Sánchez-de Prada Silvia Rojo-Rello Silvia Rojo-Rello Marta Domínguez-Gil Marta Domínguez-Gil Eduardo Tamayo-Gómez Raúl Ortiz de Lejarazu-Leonardo José María Eiros José María Eiros José María Eiros Iván Sanz-Muñoz Influenza B Lineages Have More in Common Than Meets the Eye. Trivalent Influenza Vaccines Trigger Heterotypic Antibodies Against Both Influenza B Viruses |
description |
Influenza B is accountable for an important burden during flu epidemics, causing special impact in children and the elderly. Vaccination is the best approach to address influenza infections. However, one of the main problems of this virus is that two different lineages circulate together, Victoria and Yamagata; and trivalent vaccines, that only contain one of these lineages, are still in use. For that reason, if during an epidemic, the lineage not included in the vaccine predominates, a mismatch would occur, and the vaccine effectiveness will be very poor. In this work, we evaluated the cross-protection given by the trivalent Influenza vaccine and compared serological profiles based on age, sex, and the type of vaccine used. We performed a retrospective analysis of serum samples obtained before and after seasonal influenza vaccination during 20 seasons (1998–2018). The results showed that heterotypic reactivity between both influenza B lineages is common, but always lower than the homologous response. Age is a relevant factor for this cross-reactivity between both lineages, while the sex and the type of vaccine not. Vaccination with trivalent influenza vaccines elicits cross-reactive antibodies against both lineages, however, this response might not be enough to provide an appropriate serological protection in case of mismatch. |
format |
article |
author |
Laura Sánchez-de Prada Laura Sánchez-de Prada Silvia Rojo-Rello Silvia Rojo-Rello Marta Domínguez-Gil Marta Domínguez-Gil Eduardo Tamayo-Gómez Raúl Ortiz de Lejarazu-Leonardo José María Eiros José María Eiros José María Eiros Iván Sanz-Muñoz |
author_facet |
Laura Sánchez-de Prada Laura Sánchez-de Prada Silvia Rojo-Rello Silvia Rojo-Rello Marta Domínguez-Gil Marta Domínguez-Gil Eduardo Tamayo-Gómez Raúl Ortiz de Lejarazu-Leonardo José María Eiros José María Eiros José María Eiros Iván Sanz-Muñoz |
author_sort |
Laura Sánchez-de Prada |
title |
Influenza B Lineages Have More in Common Than Meets the Eye. Trivalent Influenza Vaccines Trigger Heterotypic Antibodies Against Both Influenza B Viruses |
title_short |
Influenza B Lineages Have More in Common Than Meets the Eye. Trivalent Influenza Vaccines Trigger Heterotypic Antibodies Against Both Influenza B Viruses |
title_full |
Influenza B Lineages Have More in Common Than Meets the Eye. Trivalent Influenza Vaccines Trigger Heterotypic Antibodies Against Both Influenza B Viruses |
title_fullStr |
Influenza B Lineages Have More in Common Than Meets the Eye. Trivalent Influenza Vaccines Trigger Heterotypic Antibodies Against Both Influenza B Viruses |
title_full_unstemmed |
Influenza B Lineages Have More in Common Than Meets the Eye. Trivalent Influenza Vaccines Trigger Heterotypic Antibodies Against Both Influenza B Viruses |
title_sort |
influenza b lineages have more in common than meets the eye. trivalent influenza vaccines trigger heterotypic antibodies against both influenza b viruses |
publisher |
Frontiers Media S.A. |
publishDate |
2021 |
url |
https://doaj.org/article/871c36e087884470a75a19a47cee3f9f |
work_keys_str_mv |
AT laurasanchezdeprada influenzablineageshavemoreincommonthanmeetstheeyetrivalentinfluenzavaccinestriggerheterotypicantibodiesagainstbothinfluenzabviruses AT laurasanchezdeprada influenzablineageshavemoreincommonthanmeetstheeyetrivalentinfluenzavaccinestriggerheterotypicantibodiesagainstbothinfluenzabviruses AT silviarojorello influenzablineageshavemoreincommonthanmeetstheeyetrivalentinfluenzavaccinestriggerheterotypicantibodiesagainstbothinfluenzabviruses AT silviarojorello influenzablineageshavemoreincommonthanmeetstheeyetrivalentinfluenzavaccinestriggerheterotypicantibodiesagainstbothinfluenzabviruses AT martadominguezgil influenzablineageshavemoreincommonthanmeetstheeyetrivalentinfluenzavaccinestriggerheterotypicantibodiesagainstbothinfluenzabviruses AT martadominguezgil influenzablineageshavemoreincommonthanmeetstheeyetrivalentinfluenzavaccinestriggerheterotypicantibodiesagainstbothinfluenzabviruses AT eduardotamayogomez influenzablineageshavemoreincommonthanmeetstheeyetrivalentinfluenzavaccinestriggerheterotypicantibodiesagainstbothinfluenzabviruses AT raulortizdelejarazuleonardo influenzablineageshavemoreincommonthanmeetstheeyetrivalentinfluenzavaccinestriggerheterotypicantibodiesagainstbothinfluenzabviruses AT josemariaeiros influenzablineageshavemoreincommonthanmeetstheeyetrivalentinfluenzavaccinestriggerheterotypicantibodiesagainstbothinfluenzabviruses AT josemariaeiros influenzablineageshavemoreincommonthanmeetstheeyetrivalentinfluenzavaccinestriggerheterotypicantibodiesagainstbothinfluenzabviruses AT josemariaeiros influenzablineageshavemoreincommonthanmeetstheeyetrivalentinfluenzavaccinestriggerheterotypicantibodiesagainstbothinfluenzabviruses AT ivansanzmunoz influenzablineageshavemoreincommonthanmeetstheeyetrivalentinfluenzavaccinestriggerheterotypicantibodiesagainstbothinfluenzabviruses |
_version_ |
1718439325861937152 |